Nutriband announces data supporting need for safer abuse-deterrent transdermal patches presented at 2024 american academy of pain medicine annual meeting

Data highlights the incidence of abuse and accidental pediatric exposure of transdermal patches containing opioid and stimulant drugs nutriband's aversa™ technology addresses the unmet need for safer abuse-deterrent transdermal patches orlando, fl / accesswire / march 25, 2024 / nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that data on the incidence of transdermal patch abuse and accidental pediatric exposure was presented at the 2024 american academy of pain medicine (aapm) annual meeting on march 8, 2024. the american academy of pain medicine (aapm) is dedicated to advancing multidisciplinary pain care, education, advocacy, and research.
NTRB Ratings Summary
NTRB Quant Ranking